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Background {#sec005}
==========

Malnutrition in critically ill patients is associated with heightened mortality and morbidity rates. Up to 40% of adult patients are seriously malnourished at the time of their hospital admission, and two-thirds of all patients experience a deterioration in their nutritional status during their hospital stay.\[[@pone.0231777.ref001]\] The catabolic response in acute critically ill patients is more pronounced than that due to fasting in healthy individuals; it is superimposed by immobilization coupled with marked inflammatory and endocrine stress responses. Skeletal muscle wasting and weakness are associated with a prolonged need for mechanical ventilation, rehabilitation, and post-intensive care unit (ICU) disability.\[[@pone.0231777.ref002]\] Therefore, adequate nutrition therapy is important as an integral component in the treatment of critically ill patients. A previous multicenter study at 3 surgical ICUs (SICUs) in Thailand reported ineffective nutritional support in terms of the total calories received and the late initiation of enteral nutrition (EN).\[[@pone.0231777.ref003]\] In addition, a further study on the same population demonstrated that the combination of EN and parenteral nutrition (PN) demonstrated a protective effect on mortality.\[[@pone.0231777.ref004]\]

There have been several recommendations on medical nutrition therapy for ICU patients.\[[@pone.0231777.ref005], [@pone.0231777.ref006]\] Recently, the European Society for Parenteral and Enteral Nutrition\[[@pone.0231777.ref007]\] published revised guidelines for clinical nutrition in ICUs. However, it is necessary to use a local protocol that both follows the recommendations derived from evidence-based medicine and is adapted to local administrative practices. In a study by Barr et al. at the medical-surgical ICU of a university teaching hospital and an affiliated Department of Veterans Affairs Hospital in the USA, an evidence-based nutrition management protocol increased the likelihood that ICU patients would receive EN and shortened their duration of mechanical ventilation.\[[@pone.0231777.ref001]\] In addition, Heyland and colleagues\[[@pone.0231777.ref008]\] demonstrated that the Enhanced Protein-Energy Provision via Enteral Route Feeding protocol could increase the amount of calories and protein received. However, other recent studies did not demonstrate positive clinical outcomes for nutrition protocol use in ICUs in terms of the duration of mechanical ventilation, the incidence of nosocomial infections, and the length of stay (LOS).\[[@pone.0231777.ref009], [@pone.0231777.ref010]\] Given that, it is still controversial whether nutrition therapy protocols are effective in improving clinical outcomes. The aims of this study were therefore twofold. The first was to develop a nutrition protocol that was based on both the evidence-based guidelines and our administrative policies. The second goal was to compare the effectiveness of the nutrition therapy and the clinical outcomes including nutritional related complication, hospital and ICU mortality and length of stay of two groups: critically ill patients whose therapy followed the nutrition protocol, and critically ill patients whose therapy depended upon the clinical judgements of their attending physicians.

Materials and methods {#sec006}
=====================

A single-blind randomized controlled trial was conducted at the SICU of Siriraj Hospital November 2015--February 2017. The study was approved by the Institutional Review Board of the Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand (Si 618/2015). Written informed consent was obtained from each participant before their entry into the study. The trial was also registered with the Thai Clinical Trials Registry (TCTR20160510003).

Study population {#sec007}
----------------

The study population comprised adult patients aged 18 years or older who were admitted to the SICU, Siriraj Hospital, with an expected stay exceeding 48 hours. Excluded were patients who were tolerating an oral diet or were scheduled to return to an oral intake within 24 hours; were receiving palliative care; were moribund and not expected to survive 6 hours; were brain dead or suspected to be brain dead; had been admitted directly from another ICU; or were foreigners. Data were collected November 2015--February 2017.

Measurement instruments and data collection {#sec008}
-------------------------------------------

In the case of males, the formula used to calculate their predicted body weight (in kg) was (50.0 + 0.91\*(height in cm-- 152.4)). As to females, the predicted body weight (in kg) was given by (45.5 + 0.91\*(height in cm-- 152.4)) \[[@pone.0231777.ref011]\]. The identification of patients at nutritional risk was determined using the scores for the Nutritional Risk Screening 2002 (NRS-2002) tool\[[@pone.0231777.ref012]\], the Malnutrition Universal Screening Tool (MUST)\[[@pone.0231777.ref013]\], and the Nutrition Risk in the Critically Ill (NUTRIC)\[[@pone.0231777.ref014]\] screening tool. A score for the NRS-2002 of ≥ 3, for MUST of ≥ 2, or for NUTRIC of ≥ 5 was defined as a malnourished condition that required medical nutrition therapy. The effectiveness of the therapy was reported in terms of the time to commence it, the percentage of patients who received EN within the first 48 hours, the total daily calories received, and the proportion of patients receiving ≥ 60% of the target calories on Day 4 of their ICU admission. The nutrition-related complications were expressed as the percentage of patients who had hyper/hypoglycemia, vomiting, aspiration, abdominal distention, or a gastric residual volume ≥ 250 ml. Lastly, the clinical outcomes were the ICU mortality rate, the in-hospital mortality rate, the ICU/hospital LOS, the duration of mechanical ventilation, and the incidence of new infections developed in the ICU.

The primary outcome of this study was the effectiveness of the nutrition therapy provided by the Siriraj SICU Nutrition Protocol compared with the non-nutrition protocol. The secondary outcomes were the hospital mortality rates, hospital LOS, and ICU LOS of the protocol and non-protocol groups. In accordance with Siriraj Hospital guidelines, both groups were administered standard therapy to prevent catheter-associated blood-stream infections as well as a ventilator-associated pneumonia bundle.

Procedure {#sec009}
---------

Computerized randomization of the patients into the two study groups was done by researcher (PC, PP) in blocks of four and by using sealed envelopes. Nutrition administration in the control (non-protocol) group was done in accord with the discretion of the attending physicians. In the intervention (protocol) group, however, the nutrition management followed the "Siriraj Surgical ICU Nutrition Protocol". The patient was blind to the allocation.

After enrollment, the baseline characteristics and nutritional status data were collected. The NRS-2002 and MUST scores were used to evaluate the baseline nutritional data, while the NUTRIC score was subsequently calculated to determine the need for supplemental parenteral nutrition (SPN). In the case of the protocol group, the 100%-target calories were defined as 30 kcal per kg of predicted body weight. The Siriraj SICU Nutrition Protocol ([S1 Fig](#pone.0231777.s001){ref-type="supplementary-material"}) was started with EN within 24 hours (with the permission of the surgeons), provided there were no contraindications (such as active shock with high-dose vasopressor; tolerating an adequate oral diet, or requiring less than 24 hours to begin an oral diet; and receiving palliative care). The acceptable surgical conditions for which EN was not allowed to commence within 24 hours are detailed in Diagram 1; those conditions were re-assessed with the surgeons every 12 hours. Although total PN might be considered for those conditions, the patients were still re-assessed for EN eligibility every 12 hours. EN was commenced with a full-strength (1:1) polymeric formula. The goal was 80% of the target calories within 72 hours. A prokinetic agent was administered if that goal was not achieved; alternatively, postpyloric feeding might be considered on a case-by-case basis. In the event that the total daily calorie intake was still \< 60% of the target on Day 4 of admission, a patient's NUTRIC score would then be redetermined and the SPN Protocol would be observed ([S2 Fig](#pone.0231777.s002){ref-type="supplementary-material"}). If the NUTRIC score was ≥ 5, partial PN was initiated to reach the 100% calorie-target. On the other hand, if the NUTRIC score was \< 5, the EN was continued until Day 8. Partial PN was then commenced if the calories from the EN were still \< 60% of the target. The management of gastrointestinal intolerance is illustrated in [S3 Fig](#pone.0231777.s003){ref-type="supplementary-material"}.

Statistical analysis {#sec010}
--------------------

To compare the effectiveness of the nutrition administration protocol in the SICU, we used information drawn from a previous SICU database. It was estimated that 50% of the patients in the control group and 75% in the protocol group would achieve 100% of the target calories with statistical significance.

The sample size calculation was performed with the n4studies software (version 1.4.1) by using the formula for randomized--controlled-trial binary data with a subsequent continuity correction. The sample size in each arm was initially calculated to be 77; following the continuity correction, the size was revised to 85 for each group. The demographic and nutrition variables were presented as mean ± standard deviation and median (interquartile range) for the continuous data, and frequency and percentage for the categorical data. Group comparisons were performed by using the independent Student's t-test, Mann--Whitney U test, chi-squared test, or Fisher's exact test, as appropriate. A two-sided alpha level of 0.05 was required for statistical significance. The data were analyzed by using the Statistical Package for Social Sciences for Windows, version 18 (SPSS Inc., Chicago, IL, USA).

Results {#sec011}
=======

Of the 182 patients assessed for eligibility, 12 were excluded (ten were in the SICU for less than 48 hours; one withdrew consent; and another returned to oral intake within 24 hours). The 170 remaining patients underwent randomization, with 85 individuals in each study arm ([Fig 1](#pone.0231777.g001){ref-type="fig"}). The vast majority of the baseline demographic data of the protocol and non-protocol groups were not statistically different. That data comprised age; sex; underlying diseases; body mass index (BMI); albumin level; type of operation; sepsis at the time of admission; elective or emergency surgery; American Society of Anesthesiologists (ASA) physical status; Acute Physiology, Age, Chronic Health Evaluation (APACHE) II score; Sequential Organ Failure Assessment (SOFA) score; and the NRS-2002, MUST, and NUTRIC scores. However, significantly more protocol patients than non-protocol patients had hypertension (protocol group, 68.2%, vs. control group, 50.6%; *p* = 0.028) and vascular operations (protocol group, 25.9%, vs. control group, 13.6%; *p* = 0.048; [Table 1](#pone.0231777.t001){ref-type="table"}).

![Consort flowchart.](pone.0231777.g001){#pone.0231777.g001}

10.1371/journal.pone.0231777.t001

###### Baseline characteristics of the patients.

![](pone.0231777.t001){#pone.0231777.t001g}

  Characteristic                           Protocol (n = 85)   Control (n = 85)   *p*-value
  ---------------------------------------- ------------------- ------------------ -----------
  Age (years), (mean ± SD)                 66.6 ± 15.8         62.1 ± 16.0        0.065
  Male, n (%)                              46 (54.1)           47 (55.3)          1.000
  Body weight (kg), (mean ± SD)            61.2 ± 17.6         59.9 ± 18.2        0.637
  Body mass index (kg/m^2^), (mean ± SD)   23.3 ± 5.8          23.6 ± 6.8         0.751
  Body mass index (kg/m^2^), n (%)                                                0.484
   \< 20                                   22 (25.9)           27 (31.8)          
   ≥ 20 to \< 25                           42 (49.4)           32 (49.4)          
   ≥ 25 to \< 30                           13 (15.3)           17 (20.0)          
   ≥ 30                                    8 (9.4)             9 (10.6)           
  DM, n (%)                                34 (40.0)           24 (28.2)          0.145
  HT, n (%)                                58 (68.2)           43 (50.6)          0.028
  CKD, n (%)                               24 (28.2)           16 (18.8)          0.205
  Cirrhosis, n (%)                         8 (9.4)             10 (11.8)          0.804
  Stroke, n (%)                            19 (22.4)           11 (12.9)          0.158
  Cancer, n (%)                            25 (29.4)           32 (37.6)          0.330
  COPD, n (%)                              3 (3.5)             3 (3.5)            1.000
  Immunocompromised, n (%)                 2 (2.4)             8 (9.4)            0.050
  Type of operation, n (%)                                                        
   Intra-abdominal                         43 (53.1)           52 (64.2)          0.202
   Extra-abdominal                         17 (21.0)           18 (22.2)          0.849
   Vascular                                21 (25.9)           11 (13.6)          0.048
  ASA class ≥ 3, n (%)                     69 (86.3)           76 (93.8)          0.122
  APACHE II score, (mean ± SD)             22.6 ± 7.5          22.0 ± 6.8         0.600
  SOFA score, (mean ± SD)                  8.2 ± 3.7           7.9 ± 3.5          0.669
  Emergency at admission, n (%)            58 (71.6)           57 (70.4)          1.000
  Septic shock, n (%)                      33 (38.8)           29 (34.1)          0.633
  Albumin on admission, (mean ± SD)        2.9 ± 0.6           3.0 ± 0.7          0.176
  NRS-2002 ≥ 3, n (%)                      80 (94.1)           83 (97.6)          0.443
  MUST ≥ 2, n (%)                          12 (14.1)           18 (21.2)          0.314
  NUTRIC ≥ 5, n (%)                        59 (69.4)           47 (55.3)          0.081

Abbreviations: DM, diabetes mellitus; HT, hypertension; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; APACHE II score, acute physiology and chronic health evaluation score; ASA class, American Society of Anesthesiologists Classification; SOFA score, Sequential Organ Failure Assessment score; NRS-2002, Nutrition Risk Screening 2002; MUST, Malnutrition Universal Screening Tool; NUTRIC, Nutrition Risk in Critically Ill.

The severity of malnutrition did not significantly differ between the groups. Almost all patients in both groups were at risk of malnutrition (indicated by an NRS-2002 score ≥ 3), and more than 50% of the patients in each group had a NUTRIC score ≥ 5. Regarding the effectiveness of the nutrition therapy, the average calories received per day by both groups were not significantly different (protocol group, 775.4±342.2 kcal vs. control group, 773.0±391.9 kcal; *p* = 0.972). The median time to commence EN was shorter for the protocol patients than the control patients (1.94 and 2.25 days, respectively; *p* = 0.503\]. More than half of the patients in the two groups were given EN combined with PN (protocol group, 64.3% vs. control group, 57.1%; *p* = 0.430). In addition, a significantly higher proportion of protocol patients than control patients received EN within the first 48 hours (53.7% and 47.4%, respectively; *p* = 0.589). On the other hand, although a greater proportion of patients in the protocol group (36.5%) than in the control group (25.9%) reached the 60% calorie-target on Day 4 after admission, the difference was not statistically significant (*p* = 0.136). Nearly half of the patients in both groups were unable to receive EN due to their surgical conditions. Moreover, the main reason for interrupting or stepping up the EN was the patients' surgical conditions including gastroparesis, ileus and surgical complications (leakage and sepsis), followed by hemodynamic instability. The use of prokinetic agents in the groups did not differ ([Table 2](#pone.0231777.t002){ref-type="table"}).

10.1371/journal.pone.0231777.t002

###### Nutritional outcomes.

![](pone.0231777.t002){#pone.0231777.t002g}

  Outcome                                        Protocol (n = 85)   Control (n = 85)   *p*-value
  ---------------------------------------------- ------------------- ------------------ -----------
  EN only, n (%)                                 13 (15.5)           9 (10.7)           0.360
  PN only, n (%)                                 17 (20.2)           27 (32.1)          0.079
  EN and PN, n (%)                               54 (64.3)           48 (57.1)          0.430
  Time until EN feeding (days), median (IQR)     1.9 (0.8--3.3)      2.3 (1.2--3.6)     0.503
  Time to start of PN (days), median (IQR)       0.5 (0.1--1.2)      0.6 (0.1--1.6)     0.567
  EN within 48 hours, n (%)                      36 (53.7)           27 (47.4)          0.589
  Calories received (kcal/day), (mean ± SD)      775.4 ± 342.2       773 ± 391.9        0.972
  Calories received (kcal/kg/day), (mean ± SD)   13.5 ± 6.3          13.5 ± 7.6         0.936
  60% calorie target received on Day 4, n (%)    31 (36.5)           22 (25.9)          0.136
  Protein received (g/day), (mean ± SD)          40.3 ± 19.7         47.4 ± 22.7        0.045
  Protein received (g/kg/day), (mean ± SD)       0.7 ± 0.3           0.8 ± 0.4          0.039
  3-in-1 formula, n (%)                          33 (45.8)           37 (49.3)          0.742
  Prokinetic, n (%)                              22 (25.9)           19 (22.4)          0.591
  NPO reasons, n (%)                                                                    0.339
   Surgical condition                            40 (47.6)           46 (54.1)          
   ICU procedure                                 0                   0                  
   Unstable hemodynamics                         12 (14.3)           8 (9.4)            
  Interrupt step EN, n (%)                                                              0.936
   Surgical condition                            24 (35.3)           19 (32.2)          
   ICU procedure                                 5 (7.4)             6 (10.2)           
   Unstable hemodynamics                         4 (5.9)             3 (5.1)            
   GI intolerance                                0                   0                  

Abbreviations: EN, enteral nutrition; PN, parenteral nutrition; IQR, interquartile range; SD, standard deviation; NPO, nothing per oral; ICU, intensive care unit.

The ICU mortality rates (protocol, 12% vs. control, 18%) and hospital mortality rates (protocol, 27% vs. control, 26%) were not statistically different. The median ICU LOS was 6 days for each group (protocol group, 6.2 (4.3, 13.3) days vs. control group, 6.3 (3.6, 13.1) days). The hospital LOS and duration of mechanical ventilation were also not significantly different ([Table 3](#pone.0231777.t003){ref-type="table"}). The prevalence of nutrition--related complications and the rates of new infections in the ICU of the 2 groups were also similar. There were no statistically significant differences in the groups' nutrition-related complications (such as hyperglycemia, hypoglycemia, vomiting, and aspiration) ([Table 4](#pone.0231777.t004){ref-type="table"}).

10.1371/journal.pone.0231777.t003

###### Clinical outcomes.

![](pone.0231777.t003){#pone.0231777.t003g}

  Outcome                                     Protocol (n = 85)   Control (n = 85)    *p*-value
  ------------------------------------------- ------------------- ------------------- -----------
  Duration of mechanical ventilation (days)   4.6 (2.7--12.2)     4.9 (2.4--10.7)     0.826
  New infection, n (%)                                                                0.586
   Any infection                              28 (32.9)           29 (34.1)           
   Pneumonia                                  17 (20.0)           12 (14.1)           
  ICU mortality, n (%)                        10 (11.8)           15 (17.6)           0.279
  Hospital mortality, n (%)                   23 (27.1)           22 (25.9)           0.862
  ICU LOS (days), median (IQR)                6.2 (4.3--13.3)     6.3 (3.6--13.1)     0.574
  Hospital LOS (days), median (IQR)           27.3 (15.2--44.4)   27.1 (12.2--44.2)   0.618

Abbreviations: ICU, intensive care unit; LOS, length of stay.

10.1371/journal.pone.0231777.t004

###### Nutrition-related complications.

![](pone.0231777.t004){#pone.0231777.t004g}

  Outcome                       Protocol (n = 85)   Control (n = 85)   *P*-value
  ----------------------------- ------------------- ------------------ -----------
  Hyperglycemia, n (%)          18 (21.2)           20 (23.5)          0.713
  Hypoglycemia, n (%)           2 (2.4)             2 (2.4)            1.000
  Vomiting, n (%)               3 (3.5)             3 (3.5)            1.000
  Abdominal distension, n (%)   2 (2.4)             4 (4.7)            0.414
  Aspiration, n (%)             1 (1.2)             0                  0.316
  GRV \> 250 ml, n (%)          22 (25.9)           22 (25.9)          1.000

Abbreviations: GRV, gastric residual volume.

Although the Siriraj SICU Nutrition Protocol was administered to 85 patients, only 32 (37.6%) could receive EN within 24 hours of their admission. According to the protocol, EN was unable to be implemented for the remaining 53 patients (66%) during the initial 24-hour period due to their particular surgical conditions. Ninety percent of those patients (48 out of 53) were therefore given total PN as a substitute in that period.

Discussion {#sec012}
==========

This randomized controlled trial demonstrated that there was no significant difference between the protocol-fed and non-protocol-fed groups in terms of the effectiveness of feeding. Their efficacies were assessed by the time to commence medical nutrition therapy, the total daily calories received, the proportion of patients receiving EN within the first 48 hours, and the proportion achieving ≥ 60% of the target calorie intake on Day 4 after ICU admission. However, a higher percentage of the protocol patients received the combination of EN and PN. The protocol we created focused on the administration of SPN for surgical patients because the initiation of enteral feeding tends to be delayed for most surgical patients. Despite multiple guidelines recommending the early use of EN in ICUs,\[[@pone.0231777.ref006], [@pone.0231777.ref007]\] only half of the prescribed calories can be delivered to patients.\[[@pone.0231777.ref015]\] Because of this failure, SPN might play a role in decreasing the calorie debt, especially if patients are suffering from malnutrition.\[[@pone.0231777.ref007], [@pone.0231777.ref010], [@pone.0231777.ref016]\] The European Society for Parenteral and Enteral Nutrition guidelines recommend initiating EN within 24--48 hours for patients who are not expected to receive full oral nutrition within 3 days, and initiating SPN if the EN levels are not at goal in 48 hours.\[[@pone.0231777.ref007]\] In a recent randomized controlled trial\[[@pone.0231777.ref010]\] designed to deliver SPN only to critically ill patients who were either underweight or overweight, a significantly higher calorie intake was demonstrated for the SPN+EN arm than for the EN-alone arm. Not surprisingly, that study found that the surgical ICU patients received a poorer EN nutrition delivery but had a significantly greater increase in calorie and protein delivery when receiving SPN than did the medical ICU patients. Moreover, a subgroup analysis revealed that the patients with the highest ICU admission nutrition risk (a NUTRIC score ≥ 5) appeared to gain the most benefit from SPN. In comparison, the majority of the patients (70%) in the current study had a BMI \< 25 and a NUTRIC score ≥ 5 on admission; such a population should benefit from an SPN protocol. The PN in our study was initiated from the first day after ICU admission, and the commencement times for the protocol and non-protocol groups were not significantly different.

A previous prospective cohort study\[[@pone.0231777.ref017]\] at our SICU reported the time to start enteral feeding was approximately 4.5 days. In contrast, the present study showed shorter times of 1.9 days for the protocol group and 2.3 days for the control group. Almost half of the patients in both groups were given EN within 48 hours. As expected in this study of a SICU population, the surgical conditions were the major issues delaying both the initiation of the EN feeding and a step-up of the EN. In addition, more than half of the patients in this trial underwent intra-abdominal surgery, which might have precluded early EN feeding. Nevertheless, the time to initiate the EN was improved compared with the results from previous decades. With regard to the received calories per day during the first 7 days after admission, the average daily calorie intake was approximately 750 kcal, and there was no significant difference between the two arms. Still, a previous study\[[@pone.0231777.ref018]\] from the THAI-SICU database established a much lower level of total daily calories received (228 kcal) than did the current study. An increase in awareness of nutrition therapy and the knowledge gained from intensive course training might be the key factors that have resulted in the improvement in the effectiveness of feeding. Despite that, the effectiveness of the feedings of the protocol and non-protocol groups did not differ significantly, and there were consequently no significant differences in their clinical outcomes (new infections, hospital and ICU LOS, hospital and ICU mortality rates, and nutrition-related complications). Nonetheless, several trials have shown that the proper implementation of enteral-feeding protocols is able to reduce septic morbidity, ICU and hospital LOS, the need for mechanical ventilation, and mortality.\[[@pone.0231777.ref019]--[@pone.0231777.ref022]\] As those trials were observational in nature, the impact of an EN-feeding protocol requires further evaluation.

The strength of the present study includes its randomized controlled trial design, which employed a pragmatic nutrition protocol based on guideline recommendations\[[@pone.0231777.ref007]\] and made comparisons with a non-protocol arm (the control group). Moreover, the study established that the administration of early SPN did not result in an increased risk of infection, as had been hypothesized in a previous trial.\[[@pone.0231777.ref023]\]

Some limitations of the current research need to be addressed. Despite its randomized controlled trial design, the study was conducted at the same SICU for both the protocol and non-protocol groups; this meant that the Hawthorne effect was unavoidable. In addition, the attending physicians were assigned to take care of the patients in both study arms, and they were also the experts in nutrition therapy in the ICU. As a result, their routine nutrition therapy practice might not have differed greatly from the protocol. Finally, although our study did not show any differences in terms of the effectiveness of the feedings of the protocol and non-protocol groups, it was our observation that the clinical practice had changed in that there was an increased awareness of the need to prescribe adequate nutrition to the critically ill patients.

Conclusions {#sec013}
===========

The implementation of the nutrition protocol in the Surgical ICU did not demonstrate any significant improvement in either the effectiveness of feeding or the clinical outcomes, compared with the usual nutrition management practices.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors performed a randomized controlled trial to evaluate the efficacy of a surgical ICU nutrition protocol and to compare the groups (protocol and non) according to clinical outcomes, including 170 patients. There are some recommendations that might be useful to consider:

\- It is important to verify the use of the words efficacy x effectiveness throughout the text. In abstract it was described that the aim was to evaluate the efficacy of the protocol and to compare outcomes between groups. In the background, the aim was to develop a nutrition protocol and to compare the effectiveness of nutritional therapy and clinical outcomes. It's necessary to standardize this information.

\- Indicate in the aim which clinical outcomes were evaluated (hospital mortality, LOS,\...) - line 56

\- Indicate the reference used for the predicted body weight - lines 74 and 75

\- Indicate the reference of the scores: NRS 2002, MUST and NUTRIC - lines 76, 77 and 78

\- Provide more information about the control group. Was any nutritional risk screening applied? Is here any recommendation of the initiation of medical nutrition therapy? Or did the attending physicians decide when and how?

\- Provide more information about the follow-up and outcomes (mortality, LOS, \...). How and when were they assessed?

\- Describe the abbreviation of BMI (line 140)

\- Line 145 - p value is different from that shown in table 1

\- Line 146 - protocol group (%) and p value were different from those in table 1

\- Line 155 - p value is different from that shown in table 2

\- Table 2: describe the abbreviation of NPO

\- Cite the tables 3 and 4 in the results

\- Table 4: describe the abbreviation of GRV

\- Line 187 - PN? According to ESPEN, EN is the first choice for nutrition support during the first three to four days after ICU admission. If EN is not feasible or is insufficient after three days, PN should be prescribed

\- CONSORT checklist - item 12b: The authors listed that additional analyses were in page 7. What analyses were done in addition to the others presented?

\- CONSORT checklist - item 21: It is important to include the external validity and applicability of the trial findings.

Reviewer \#2: The present manuscript shows the results of a clinical trial where a protocol for improving nutrition therapy in surgical ICU patients was tested.

1)While the use of protocols to improve clinical nutrition is still an issue, I presume that this kind of strategy should be useful when none management has been used in the current practice. Therefore, I suggest the authors to state the routine management of ICU surgical patients. If the current routine and the protocol have similar strategies, the clinical trial would not be the best option to state that protocol-based nutrition therapy doesn't work.

2\) Lines 15 and 16 abstract and 152 -153 -- suggest the time to commence the nutrition therapy tended to be shorter in the protocol group. However, the P-value is too high to say tendency.

3\) 125 - Which outcome do you consider to calculate the sample size?

4\) Line 159 -- The authors observed that surgical conditions delay enteral nutrition delivery in almost 50% of patients. May you explain better about this? Did the patients develop metabolic ileus, distension, fistula?

5\) Do you use Enhanced recovery after surgery strategies, such as reducing volume overload, reducing fasting time, etc.? Regarding pre and intra-surgical management, my question here is: Is the protocol that doesn't work? Or in both groups, the patients have not been well prepared to receive enteral nutrition in the first 24-48 days.

5\) May you explain about diarrhea? There is a protocol involving this complication that could reduce nutrition delivery, but I couldn't find data about it.

6\) Table 2 -- page 18. The hypocaloric diet is expected for the first days of ICU hospitalization. However, the amount of protein is too low and different between the goups. May you explain about it?

7\) Which type of vascular surgery? Large surgeries for an aortic replacement, for example, are completely different from varicose vein. While vascular surgery was more common in the protocol group, could the type of surgery have any influence?

Reviewer \#3: The present study aimed to evaluate the effectiveness of a surgical nutrition protocol in the ICU and to compare hospital mortality, length of hospital stay and length of stay in the ICU of the protocol and non-protocol groups. Although the study is methodologically well developed, some problems make its result difficult to interpret.

1- how to explain the ineffectiveness of the nutritional protocol? Both groups (protocol and non-protocol) had around 50% of patients receiving nutritional therapy in the first 48 hours. This rate is low, but is close to that reported in recent literature (PLoS One. 2017 Aug 3; 12 (8): e0182393. Doi: 10.1371 / journal.pone.0182393; World J Crit Care Med. 2017 Feb 4; 6 ( 1): 56-64.doi: 10.5492 / wjccm.v6.i1.56; Asia Pac J Clin Nutr. 2017 Jan; 26 (1): 27-35.doi: 10.6133 / apjcn.122015.01; among others). So, the central question is: why don\'t we feed almost 50% of patients?

2- Differences in outcomes will not be seen, since there was no difference between the protocol and non-protocol groups. Wouldn\'t it be interesting to see if the diet receiving quartiles had different outcomes?

Minor considerations:

1 - it was not possible to understand which method of nutritional assessment was used. Was NRS, MUST or Nutric used for the diagnosis of malnutrition? If they gave different diagnoses, which one would be considered?

2- how was the height of the patients obtained (used for the ideal weight formula)?

3- Did you use the ideal weight even in the patient with a BMI below 30 kg / m? The ESPEN guideline, 2019, indicates the use of current weight.

4- What weight was used for the screening / nutritional assessment tools? And how was this weight obtained?

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

26 Feb 2020

Editor comments:

Although the study is methodologically well developed, some problems make its result difficult to interpret and decrease its relevance. Please, try to clarify some points:

1\. Differences in outcomes will not be seen, since there was no difference between the protocol and non-protocol groups. Wouldn\'t it be interesting to see if the diet receiving quartiles had different outcomes?

Answer: When we considered 50%, 40% and 30% calorie target received on Day 4 instead of 60% calorie target received on Day 4 as we had reported on table 2, the difference between protocol and control groups regarding calorie target received on Day 4 remains non-significant.

Nutrition outcomes Protocols (n=85) Control (n=85) p-value

50% calorie target received on Day 4, n (%) 42(49.4%) 29(34.1%) 0.062

40% calorie target received on Day 4, n (%) 47(55.3%) 36(42.4%) 0.125

30% calorie target received on Day 4, n (%) 54(63.5%) 46(54.1%) 0.280

2\. It was not possible to understand which method of nutritional assessment was used. Was NRS, MUST or Nutric used for the diagnosis of malnutrition? If they gave different diagnoses, which one would be considered?

Answer: Since no specific ICU nutritional score has been validated thus far. The existing nutritional screening tools NRS 2002 and the malnutrition universal screening tool (MUST) score have not been designed specifically for critically ill patients, we decided to present both NRS and MUST for baseline nutrition assessment at ICU admission and there were not significantly different between protocol and non-protocol groups. However, we used Nutric at day 4 to define malnutrition in order to commence parenteral nutrition.

3\. How was the height of the patients obtained (used for the ideal weight formula)?

Answer: We measured the height by the tape measure in patients who did not have the height recorded in the medical records or used the height that recorded in the medical record in patients who had that records.

4\. Did you use the ideal weight even in the patient with a BMI below 30 kg / m? The ESPEN guideline, 2019, indicates the use of current weight.

Answer: Yes, we used the ideal body weight in all patients. We did this study before the recommendation from ESPEN 2019. However, in the majority of Thai population the actual and ideal body weight is not much different and both the body weight and BMI were not significantly different between groups.

5\. What was weight used for the screening / nutritional assessment tools? And how was this weight obtained?

Answer: In the case of males, the formula used to calculate their predicted body weight (in kg) was (50.0 + 0.91\*\[height in cm -- 152.4\]). As to females, the predicted body weight (in kg) was given by (45.5 + 0.91\*\[height in cm -- 152.4\]) (line 73-75). The height was obtained as mentioned in question 3.

Journal Requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Answer: Thank you for your suggestion. We did it as suggestion.

2\. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (<http://learn.aje.com/plos/>) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website ([www.editage.com](http://www.editage.com)) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

• The name of the colleague or the details of the professional service that edited your manuscript

• A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a \*supporting information\* file)

• A clean copy of the edited manuscript (uploaded as the new \*manuscript\* file)

Answer: Thank you for your suggestion. We send to language editing by a native English speaker and edited manuscript (Mr. David William Park, faculty of Medicine Siriraj hospital) formatting according to the guidelines of journal.

3\. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 and 4 in your text; if accepted, production will need this reference to link the reader to the Table.

Answer: We added as suggestion. We referred to Table 3 and 4 in manuscript (page 9, results, paragraph 3, line 168 and line 172).

Reviewers\' comments:

Reviewer\'s Responses to Questions

Comments to the Author

1\. Is the manuscripts technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

Reviewer \#3: Yes

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

Reviewer \#2: Yes

Reviewer \#3: Yes

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors performed a randomized controlled trial to evaluate the efficacy of a surgical ICU nutrition protocol and to compare the groups (protocol and non) according to clinical outcomes, including 170 patients. There are some recommendations that might be useful to consider:

\- It is important to verify the use of the words efficacy x effectiveness throughout the text. In abstract it was described that the aim was to evaluate the efficacy of the protocol and to compare outcomes between groups. In the background, the aim was to develop a nutrition protocol and to compare the effectiveness of nutritional therapy and clinical outcomes. It's necessary to standardize this information.

Answer: Thank you for your suggestion. We changed the "efficacy to effectiveness" in entire manuscript.

\- Indicate in the aim which clinical outcomes were evaluated (hospital mortality, LOS,\...) - line 56

Answer: We added as suggestion. (nutritional related complications, hospital and ICU mortality and length of stay).

\- Indicate the reference used for the predicted body weight - lines 74 and 75

Answer: We added as suggestion (page 5, materials and methods, line 75).

Reference:

11\. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England journal of medicine. 2000;342(18):1301-8.

\- Indicate the reference of the scores: NRS 2002, MUST and NUTRIC - lines 76, 77 and 78

Answer: We added as suggestion (page 5, materials and methods, line 76, 77, 78).

Reference:

12\. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415-21.

13\. Elia M. The \'MUST\' report. Nutritional screening for adults: a multidisciplinary responsibility. Development and use of the \'Malnutrition Universal Screening Tool\' (MUST) for adults.: British Association for Parenteral and Enteral Nutrition (BAPEN); 2003.

14\. Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Critical care (London, England). 2011;15(6):R268.

\- Provide more information about the control group. Was any nutritional risk screening applied? Is here any recommendation of the initiation of medical nutrition therapy? Or did the attending physicians decide when and how?

Answer: Nutritional risk screening was not applied routinely for the control group, we calculated for this study without informing the attending staff. No any nutritional guidelines had been available in SICU before, the nutritional therapy was made by the attending physicians at any time or any methods.

\- Provide more information about the follow-up and outcomes (mortality, LOS, \...). How and when were they assessed?

Answer: ICU, In-hospital mortality, LOS and nutrition related complication, data was retrieved from the researcher (prospective data mining from medical records) in the study (PC, PP, PT)

\- Describe the abbreviation of BMI (line 140)

Answer: We did as suggestion.

\- Line 145 - p value is different from that shown in table 1

Answer: Thank you for pointing out this error. We have checked the results as suggested (page 8, results, paragraph 1, line 145).

\- Line 146 - protocol group (%) and p value were different from those in table 1

Answer: Thank you for pointing out this error. We have checked the results as suggested (page 8, results, paragraph 1, line 146).

\- Line 155 - p value is different from that shown in table 2

Answer: Thank you for pointing out this error. We have checked the results as suggested (page 8, results, paragraph 2, line 154-162).

\- Table 2: describe the abbreviation of NPO

Answer: We did as suggestion.

\- Cite the tables 3 and 4 in the results

Answer: We did as suggestion.

\- Table 4: describe the abbreviation of GRV

Answer: We did as suggestion.

\- Line 187 - PN? According to ESPEN, EN is the first choice for nutrition support during the first three to four days after ICU admission. If EN is not feasible or is insufficient after three days, PN should be prescribed

Answer: Thank you for the correction, we have changed PN to EN.

\- CONSORT checklist - item 12b: The authors listed that additional analyses were in page 7. What analyses were done in addition to the others presented?

Answer: Thank you for pointing out. We have corrected the CONSORT checklist item 12b...No additional analyses.

\- CONSORT checklist - item 21: It is important to include the external validity and applicability of the trial findings.

Answer: We pointed out in the discussion, line 232-235.

Reviewer \#2: The present manuscript shows the results of a clinical trial where a protocol for improving nutrition therapy in surgical ICU patients was tested.

1\) While the use of protocols to improve clinical nutrition is still an issue, I presume that this kind of strategy should be useful when none management has been used in the current practice. Therefore, I suggest the authors to state the routine management of ICU surgical patients. If the current routine and the protocol have similar strategies, the clinical trial would not be the best option to state that protocol-based nutrition therapy doesn't work.

Answer: We totally agree. Basically, nutritional risk screening was not applied routinely for the control group, we calculated the scores for this study without informing the attending staff. No any nutritional guidelines had been available in SICU before, the nutritional therapy was made by the attending physicians at any time or any methods. However, the faculty provided education regarding the nutrition therapy to critical care fellow and residents that occurred during the study period. Although we haven't had any protocol before, the healthcare providers might have better knowledge regarding nutrition therapy.

2\) Lines 15 and 16 abstract and 152 -153 -- suggest the time to commence the nutrition therapy tended to be shorter in the protocol group. However, the P-value is too high to say tendency.

Answer: We corrected from tended to "was".

3\) 125 - Which outcome do you consider to calculate the sample size?

Answer: It was estimated that 50% of the patients in the control group and 75% in the protocol group would achieve 100% of the target calories with statistical significance. We used the effectiveness of nutrition therapy in term of achieve 100% of the target calories.

4\) Line 159 -- The authors observed that surgical conditions delay enteral nutrition delivery in almost 50% of patients. May you explain better about this? Did the patients develop metabolic ileus, distension, fistula?

Answer: We added more detail about surgical conditions. Moreover, the main reason for interrupting or stepping up the EN was the patients' surgical conditions including gastroparesis, ileus and surgical complication (leakage and sepsis), followed by hemodynamic instability. (page 9, paragraph 2, line 161)

5\) Do you use Enhanced recovery after surgery strategies, such as reducing volume overload, reducing fasting time, etc.? Regarding pre and intra-surgical management, my question here is: Is the protocol that doesn't work? Or in both groups, the patients have not been well prepared to receive enteral nutrition in the first 24-48 days.

Answer: During the study period, our hospital did not use the ERAS protocol. We just implemented the ERAS on November, 2019. We tried our best to commence EN as soon as possible according to the protocol, however, the decision was depended on each surgeon even we had informed about the protocol.

5\) May you explain about diarrhea? There is a protocol involving this complication that could reduce nutrition delivery, but I couldn't find data about it.

Answer: Since there was less than 20% of patients in both groups received only EN (table 2), no clinical significant diarrhea (clinical significant stools, diagram 3) was reported from our cohort.

6\) Table 2 -- page 18. The hypocaloric diet is expected for the first days of ICU hospitalization. However, the amount of protein is too low and different between the groups. May you explain about it?

Answer: We did not know the exact reasons. According to the protocol, we did not target the amount of delivered protein and the mean calories received was quite low due to surgical conditions that preclude early feeding including gastroparesis, ileus and surgical complications (leakage and sepsis). Moreover, the effectiveness of the therapy was reported in terms of the time to commence it, the percentage of patients who received EN within the first 48 hours, the total daily calories received, and the proportion of patients receiving \> 60% of the target calories on Day 4 of their ICU admission.

7\) Which type of vascular surgery? Large surgeries for an aortic replacement, for example, are completely different from varicose vein. While vascular surgery was more common in the protocol group, could the type of surgery have any influence?

Answer: The majority of vascular surgery in our SICU was major aortic surgery including infrarenal aortic aneurysm surgery, the acute limb ischemia from arterial occlusion and the bypass surgery. Although the number of vascular surgeries was higher in protocol group, the severity of patients measured by APACHE II and SOFA score was not significantly different between groups.

Reviewer \#3: The present study aimed to evaluate the effectiveness of a surgical nutrition protocol in the ICU and to compare hospital mortality, length of hospital stay and length of stay in the ICU of the protocol and non-protocol groups. Although the study is methodologically well developed, some problems make its result difficult to interpret.

1- how to explain the ineffectiveness of the nutritional protocol? Both groups (protocol and non-protocol) had around 50% of patients receiving nutritional therapy in the first 48 hours. This rate is low, but is close to that reported in recent literature (PLoS One. 2017 Aug 3; 12 (8): e0182393. Doi: 10.1371 / journal.pone.0182393; World J Crit Care Med. 2017 Feb 4; 6 ( 1): 56-64.doi: 10.5492 / wjccm.v6.i1.56; Asia Pac J Clin Nutr. 2017 Jan; 26 (1): 27-35.doi: 10.6133 / apjcn.122015.01; among others). So, the central question is: why don\'t we feed almost 50% of patients?

Answer: The main reason for interrupting or stepping up the EN was the patients' surgical conditions including gastroparesis, ileus and surgical complication (leakage and sepsis), followed by hemodynamic instability. This was the main reason for ineffectiveness of a surgical nutrition protocol in SICU. In addition, the decision to start feeding partly depended on surgeon that we mentioned in the guidelines (with surgeon's permission, table 1).

2- Differences in outcomes will not be seen, since there was no difference between the protocol and non-protocol groups. Wouldn\'t it be interesting to see if the diet receiving quartiles had different outcomes?

Answer: When we considered 50%, 40% and 30% calorie target received on Day 4 instead of 60% calorie target received on Day 4 as we had reported on table 2, the differences between protocol and control group regarding calorie target received on Day 4 remains non-significant.

Nutrition outcomes Protocols (n=85) Control (n=85) p-value

50% calorie target received on Day 4, n (%) 42(49.4%) 29(34.1%) 0.062

40% calorie target received on Day 4, n (%) 47(55.3%) 36(42.4%) 0.125

30% calorie target received on Day 4, n (%) 54(63.5%) 46(54.1%) 0.280

Minor considerations:

1 - it was not possible to understand which method of nutritional assessment was used. Was NRS, MUST or Nutric used for the diagnosis of malnutrition? If they gave different diagnoses, which one would be considered?

Answer: Since no specific ICU nutritional score has been validated thus far. The existing nutritional screening tools NRS 2002 and the malnutrition universal screening tool (MUST) score have not been designed specifically for critically ill patients, we decided to present both NRS and MUST for baseline nutrition assessment at ICU admission and there were not significantly different between protocol and non-protocol groups. However, we used Nutric at day 4 to define malnutrition in order to commence parenteral nutrition.

2- how was the height of the patients obtained (used for the ideal weight formula)?

Answer: We measured the height by the tape measure in patients who did not have the height recorded in the medical record or used the height that recorded in the medical record in patients who had that record.

3- Did you use the ideal weight even in the patient with a BMI below 30 kg / m? The ESPEN guideline, 2019, indicates the use of current weight.

Answer: Yes, we used an ideal body weight in all patients. We did this study before the recommendation from ESPEN 2019. However, in the majority of Thai population the actual and ideal body weight is not much different and both the body weight and BMI were not significantly different between groups.

4- What weight was used for the screening / nutritional assessment tools? And how was this weight obtained?

Answer: In the case of males, the formula used to calculate their predicted body weight (in kg) was (50.0 + 0.91\*\[height in cm -- 152.4\]). As to females, the predicted body weight (in kg) was given by (45.5 + 0.91\*\[height in cm -- 152.4\]) (line 73-75). The height was obtained as mentioned in question 2.

6\. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.
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Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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